- Home
- TLSA
as 07-26-2024 4:00pm EST
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
| Founded: | 2013 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | 84.3M | IPO Year: | 2000 |
| Target Price: | N/A | AVG Volume (30 days): | 191.1K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.17 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.41 - $1.10 | Next Earning Date: | 08-06-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Tiziana Life Sciences Ltd. News
TLSA Breaking Stock News: Dive into TLSA Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
Tiziana Life Sciences Granted FDA Fast Track Designation
MT Newswires
a month ago
Tiziana Life Sciences Gets $3.4 Million in Funding for Neurodegenerative Disease Studies
GlobeNewswire
a month ago
Tiziana Receives $3.4 Million in Non-Dilutive Funding
GlobeNewswire
a month ago
Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer’s Disease with Foralumab
MT Newswires
a month ago
Tiziana Says FDA Accepts Fast Track Label Submission For Multiple Sclerosis Treatment
GlobeNewswire
2 months ago
FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclerosis
Investor's Business Daily
2 months ago
IBD Stock Of The Day Meta Rolls Out New AI Tools For Businesses
Business Wire
2 months ago
Credo AI Launches the World's Largest and Most Comprehensive AI Risk and Controls Library
Compare TLSA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TLSA Tiziana Life Sciences Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.